On August 9, 2018, the Supreme Court of Canada denied Sobeys’ application for leave to appeal (docket no. 37864) from the Alberta Court of Appeal (ABCA)’s decision in a dispute regarding the Alberta College of Pharmacists (the “College”)’s policy prohibiting pharmacists/pharmacies from offering loyalty rewards programs or inducements to patients.
The ABCA held that the policy was intra vires the College under the Health Professions Act and reasonable (Alberta College of Pharmacists v Sobeys West Inc., 2017 ABCA 306), disagreeing with the application judge regarding the appropriate standard of review and on the merits (Sobeys West Inc. v Alberta College of Pharmacists, 2016 ABQB 138; Sobeys West Inc. v Alberta College of Pharmacists, 2016 ABQB 232).
This decision follows the Supreme Court’s 2016 refusal to grant Sobeys leave to appeal a British Columbia Court of Appeal decision allowing the College of Pharmacists of British Columbia to prohibit “customer incentive programs”: Sobeys West Inc. v College of Pharmacists of British Columbia, 2016 BCCA 41; SCC docket no. 36917.
Related Publications & Articles
-
2026 mid-year highlights in Canadian life sciences IP and regulatory law
In the first half of 2026, the Rx IP Update team reported on a number of developments in Canadian life sciences IP and regulatory law. Below are our top storiesRead More -
Supreme Court of Canada: methods of medical treatment unpatentable, validity of Janssen’s paliperidone dosing regimen patent upheld
Today the Supreme Court of Canada released its decision in Pharmascience Inc v Janssen Inc, 2026 SCC 26 on the patentability of methods of medical treatment, dismissing Pharmascience’s appeal.Read More -
Health Canada obtains permanent injunction to prevent illegal sale of injectable peptides by Canlab Research
On July 29, 2026, Health Canada announced that it obtained a permanent injunction from the Superior Court of Québec against Canlab Research and its representatives preventing them from selling “unauth...Read More
